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Sonic hedgehog (Shh) signaling controls numerous aspects of vertebrate development, including proliferation of precursors in different organs.
Identification of molecules that link the Shh pathway to cell cycle machinery is therefore of major importance for an understanding of the
mechanisms underlying Shh-dependent proliferation. Here, we show that an actor in the control of entry into mitosis, the phosphatase CDC25B, is
transcriptionally upregulated by the Shh/Gli pathway. Unlike other G2/M regulators, CDC25B is highly expressed in domains of Shh activity,
including the ventral neural tube and the posterior limb bud. Loss- and gain-of-function experiments reveal that Shh contributes to CDC25B
transcriptional activation in the neural tube both of chick and mouse embryos. Moreover, CDC25B transcripts are absent from the posterior limb
bud of Shh−/− mice, while anterior grafts of Shh-expressing cells in the chicken limb bud induce ectopic CDC25B expression. Arresting the cell
cycle does not reduce the level of CDC25B expression in the neural tube strongly suggesting that the upregulation of CDC25B is not an indirect
consequence of the Shh-dependent proliferation. These data reveal an unexpected developmental link between the Shh pathway and a participant
in G2/M control.
© 2006 Elsevier Inc. All rights reserved.Keywords: CDC25B; Shh; Neural tube; Limb bud; Cell cycle; DevelopmentIntroduction
The hedgehog (hh) signaling pathway controls several
aspects of vertebrate life, intervening in phenomena as varied
as patterning and growth of embryonic structures, renewal of
stem cells and certain processes of regeneration and tissue repair
(Beachy et al., 2004). During embryonic development, Sonic
hedgehog (Shh) plays a key role in the establishment of bilateral
asymmetry, in ventral patterning of the central nervous system
and in morphogenesis of the limb (reviewed in (McMahon et
al., 2003). In the chick embryo, Shh is expressed asymmetri-
cally during and after gastrulation at the left of Hensen's node,
and is part of the cascade that determines bilateral asymmetry,
ensuring the invariant left–right position of organs in the adult⁎ Corresponding author. Fax: +33 5 61 55 65 07.
E-mail address: pituello@cict.fr (F. Pituello).
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doi:10.1016/j.ydbio.2006.02.035body (Levin et al., 1995). During spinal cord elongation, Shh
activity, absent from the caudal neuroepithelium, where it is
inhibited by FGF signaling, appears as a ventro-dorsally
decreasing gradient in the closing neural tube (del Corral et
al., 2003; Novitch et al., 2003). It is subsequently a key actor in
the specification of ventral neuronal subtypes in the spinal cord,
where it operates as a morphogen, i.e., a graded signal that
triggers distinct threshold responses, thereby specifying a series
of different fates (reviewed in Marquardt and Pfaff, 2001;
Wilson and Maden, 2005). The Shh morphogenetic action in the
neural tube is mediated by the gradient activity of activator or
repressor transcription factors of the Gli family: Gli1, Gli2 and
Gli3 (Ruiz i Altaba et al., 2003; Stamataki et al., 2005). Shh is
also the signal produced by the zone of polarizing activity
(ZPA), that is responsible for normal antero-posterior patterning
of the limb and the control of digit identities (Zeller, 2004). In
this case, identities are specified not only by the level of
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(Ahn and Joyner, 2004; Harfe et al., 2004).
Besides mediating morphogenic responses, the hh signaling
pathway has been shown to govern the size of different
structures in the embryo by acting on cell growth (Duman-
Scheel et al., 2002; Gritli-Linde et al., 2002), cell survival and/
or cell proliferation (Ahlgren and Bronner-Fraser, 1999;
Charrier et al., 2001; Jeong et al., 2004; Machold et al., 2003;
Thibert et al., 2003; Cayuso et al., 2006), the latter being
particularly well documented for the central nervous system
(reviewed in Ruiz et al., 2002). During embryonic development,
Shh acts as a mitogen in the primordia of ventral and dorsal
regions of the diencephalon and midbrain in early somite-stage
mouse embryos (Britto et al., 2002; Ishibashi and McMahon,
2002). The spinal cord of mouse embryos misexpressing Shh
displays overgrowth due to an overproliferation (Rowitch et al.,
1999). Mice lacking negative feedback of hh signaling have a
larger neural tube, possibly due to small increase in proliferation
or survival rates that have cumulative effects over time (Jeong
and McMahon, 2005). A recent analysis performed in chicken
spinal cord shows that Shh/Gli activity acts directly at long
range to promote the proliferation and survival of progenitor
cells (Cayuso et al., 2006). During midembryogenesis, the
dorsal aspect of the brain, including the neocortex and
cerebellum, undergoes rapid extension and Shh has been
shown to promote proliferation of cerebellar granule cells and
neocortical precursors (Dahmane and Ruiz-i-Altaba, 1999;
Dahmane et al., 2001; Wallace, 1999; Wechsler-Reya and Scott,
1999); reviewed by Ruiz et al., 2002). In the adult brain,
neurogenesis occurs in the subventricular zone of the lateral
ventricular walls of the forebrain and in the subgranular layer of
the dentate gyrus of the hippocampus and Shh is required for
neural progenitor proliferation in both areas (Lai et al., 2003;
Machold et al., 2003; Palma and Ruiz i Altaba, 2004; Palma et
al., 2005). Thus, accumulated evidence reveals that Shh is
extensively involved in the control of cell proliferation. As a
corollary, deregulation of this pathway has been associated with
the initiation and growth of several cancers (Ruiz i Altaba et al.,
2004).
The normal function of Shh signaling in the control of cell
proliferation and its pathological role in the growth of malignant
tumors make obvious the need to identify the effectors driving
Shh-dependent proliferation. Mitogens enable cell cycle
progression by permitting a bypass of the restriction point that
divides the cell cycle into a growth factor-dependent phase
(early G1) and a growth factor-independent phase (from late G1
through mitosis) (Ho and Dowdy, 2002). The target of mitogens
is D-type cyclins, which assemble with cyclin-dependent
kinases CDK4/6 and promote G1-S transition. The proposed
role of D-type cyclins in coupling extracellular signals to the
cell cycle machinery makes them ideal candidates to mediate
Shh-dependent proliferation. Indeed, in Drosophila, hh signal-
ing promotes transcription of cyclin D, thus regulating both cell
growth (defined here as increase in mass) and proliferation
(Duman-Scheel et al., 2002). In vertebrates, there are three D-
type cyclins (D1, D2 and D3) and cyclin D1 and D2 are
transcriptional targets mediating the mitogenic response to Shhof cerebellar granule cell precursors (Dahmane and Ruiz-i-
Altaba, 1999; Kenney and Rowitch, 2000; Kenney et al., 2003;
Oliver et al., 2003; Wallace, 1999; Wechsler-Reya and Scott,
1999). Loss of Shh function impedes the growth of both ventral
and dorsal regions of diencephalon and midbrain, a growth
defect associated with downregulation of cyclin D1 expression
(Britto et al., 2002; Ishibashi and McMahon, 2002). The
initiation of cyclin D1 expression in the spinal cord primordium
depends specifically on Shh and its maintenance in the neural
tube favors proliferation at the expense of neuronal differenti-
ation (Lobjois et al., 2004). All together, these data show that,
like other mitogens, Shh acts on D-cyclins to favor G1
progression during the cell cycle. In Drosophila, hh signaling
has also been shown to promote proliferation by directly
upregulating cyclin E expression, thus inducing DNA replica-
tion (Duman-Scheel et al., 2002), but there is as yet no evidence
of such a connection in vertebrates. In vertebrate spinal cord,
differentiation of ventralized progenitors into motor neurons
seems to depend on two distinct periods of Shh signaling,
including one late in the S phase but the molecular target is
unknown (Ericson et al., 1996).
A link has also been observed between the Shh pathway and
the G2/M transition in cell lines (Barnes et al., 2001). Entry into
mitosis requires the activation of the M-phase promoting factor
(MPF). The MPF consists of two proteins: the kinase CDK1 and
the cyclin B1 (Doree and Hunt, 2002). At late G2, cyclin B-
CDK1 translocates to the nucleus where it phosphorylates many
nuclear substrates required for mitotic progression. In cell lines,
the receptor of Shh, Patched 1, has been shown to interact with
phosphorylated cyclin B1, thus maintaining it in the cytoplasm,
while addition of Shh disrupts this interaction and allows cyclin
B1 to localize to the nucleus (Barnes et al., 2001). However, the
biological significance of such an interaction in vivo remains to
be elucidated.
Activation of the cyclin B-CDK1 kinase is a key event
required for the initiation of mitosis. This enzyme is normally
maintained in an inactive state by phosphorylation of Thr14 and
Tyr 15 by the Wee1 and Myt1 kinases. It is activated at the entry
into mitosis by the CDC25 phosphatases, which dephosphor-
ylate these residues (Kristjansdottir and Rudolph, 2004). In
vertebrates, three phosphatases (A, B and C) of the CDC25
family have been identified, two of which, CDC25B and
CDC25C, are regulators of G2/M transition while CDC25A has
a more general role, being involved in both G1/S and G2/M cell
cycle transitions (Donzelli and Draetta, 2003). CDC25A and B
are both needed for mitotic entry, whereas CDC25C alone
cannot induce mitosis (Lindqvist et al., 2005). Furthermore,
CDC25A and B exert specific functions in the initiation of
mitosis: CDC25A may play a role in chromatin condensation,
whereas CDC25B specifically activates Cyclin B1-CDK1 on
centrosomes (Dutertre et al., 2004; Lindqvist et al., 2005).
CDC25B is also required for efficient mitotic entry after a
DNA-activated G2 checkpoint arrest (van Vugt et al., 2004). In
chicken sequence databases, we found only two of these
phosphatases, CDC25A and B. Here, we accumulate evidence
showing that CDC25B is linked to Shh signaling in early
embryonic patterning events. Thus, CDC25B is expressed
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dorsally decreasing gradient in the closing neural tube and a
posterio-anteriorly decreasing gradient in the developing limb
bud. Furthermore, we demonstrate, by loss- and gain-of-
function experiments, that Shh signaling upregulates CDC25B
in the neural tube and in the limb bud of both chick and mouse
embryos. Arresting the cell cycle does not affect the ventro-
dorsal gradient of CDC25B expression in the neural tube
suggesting that Shh is able to upregulate CDC25B indepen-
dently of its effect on proliferation. All together, these data
establish a novel link between the Hh pathway and the cell cycle
machinery and suggest that the Hh pathway may control the G2/
M transition; at least part of this control may proceed through
transcriptional regulation of CDC25B.
Materials and methods
Embryos
Fertile hens' eggs were incubated at 38°C in a humidified incubator to yield
embryos of appropriate stages (Hamburger and Hamilton, 1992). Mouse
embryos were collected at various stages, considering the morning when vaginal
plug was detected as day 0.5 p.c. Shh-deficient embryos were a gift from R.
Zeller.
Modulation of the Shh signaling pathway
Cyclopamine administration and electroporation of Shh cDNA, Gli2ΔN-
term or Gli3ΔN-term were performed as described elsewhere (Lobjois et al.,
2004). Gli2ΔN-term and Gli3ΔN-term were a gift of M.P. Matise (Lei et al.,
2004). Injection of cyclopamine was performed using a glass needle from the
hindbrain to the posterior region of the neural tube. Pellet implantations in the
limb bud were performed as described in Riddle et al. (1993) using cells
prepared as described in Poncet et al. (1996).
Drug administration for cell cycle arrest
Cell cycle arrest was achieved by incubating embryos in petri dishes in
Tyrode's solution supplemented with Aphidicolin (5 to 16 μM), mimosin
(400 μM) or hydroxyurea (1 to 2 mM) for 3 or 4 h at 38°C. Control embryos
were treated with Dimethylsulfoxide (DMSO) alone under the same conditions.
In situ hybridization
In situ hybridization was performed as previously described (Lobjois et al.,
2004). CDC25B expression patterns were analyzed in chicken embryos using
the antisense digoxigenin-RNA probe prepared from the ChEST203l5 (obtained
from the HGMP-RC) coding for part of the CDC25B cDNA. Cyclin B2 was a
gift of E. Nigg (Gallant and Nigg, 1992). Fragments of chicken CDC25A and
CDK1 coding regions were obtained by PCR. The primers used were: 5′-
CTGCAGCAGAAATTGAGAGC-3′ and 5′-CAATTAACCCTCACTAAAGG-
GATGTGGTGATGTGC-3′ for CDC25A; 5′-CCACAGCCATGGAGGAT-
TAC-3′ and 5′-CACATCAGGCCACACATCAT-3′ for CDK1.
In gain-of-function experiments, probes were synthesized from isolated
specific PCR fragments to avoid any cross-reactivity with the transgenes.
CDC25A was obtained by means of the primers described above or with the
following primers (5′-AGCGACATCAGAGAGGAAAC-3′ and 5′-CAAT-
TAACCCTCACTAAAGGGCTCTCAATTTCTGC-3′) allowing to amplify
the regulatory domain of CDC25A which displays less than 60% homology
with CDC25B; each probe gave the same data; CDC25B with 5′-GGAG-
CCCTGCGTGCCGAG-3′ and 5′-CAATTAACCCTCACTAAAGGG-
TCCTGGTGTTTGCC-3′. GFP and Shh transgenes were detected using
fluorescein-RNA probes synthesized as described previously (Lobjois et al.,
2004). A fragment of mouse CDC25B coding regions was obtained by PCR.The primers used were: 5′-ACTCCTGTCGAAAGGGCTTC-3′ and 5′-GCA-
GAAAGGTCTCAGCATCC-3′. Vibratome sectioning was performed as pre-
viously described (Lobjois et al., 2004).
Immunohistochemistry
Immunohistochemistry was performed following in situ hybridization to
detect the pellet of quail fibroblasts using QCPN antibody (Developmental
Studies Hybridoma Bank) (Selleck and Bronner-Fraser, 1995). The primary
antibody was applied at 1/2 dilution overnight at 4°C prior detection with a
Vectastain kit (Vector laboratories) following manufacturer's instructions.
Cell proliferation analysis
Cell proliferation was evaluated by bromodeoxyuridine (BrdU) incorpora-
tion (BrdU labeling and detection kit I, Roche). BrdU (10 mM) was injected into
the lumen of the neural tube and the embryos were harvested 30 min later. Cells
expressing the phospho-Histone H3 (P-H3) were visualized by performing
immunocytodetection with the polyclonal anti-P-H3 antibody (Upstate
biotechnology, dilution 1/1000). BrdU and P-H3 immunodetections were
performed on 12 μm frozen sections as previously described (Lobjois et al.,
2004). Immunodetection of P-H3 after in situ hybridization was performed by
using the Vectastain kit.
Flow cytometry analysis
A piece of neural tube was cut from control or treated embryos
corresponding to the prospective −V to +V somite level in the presence of 1×
pancreatin (Gibco). The explants were stored in ice-cold PBS plus 2% BSA for
less than 1 h and samples of 3 explants each centrifuge at 1000 × g for 5 min.
The supernatant was then discarded and the sample stored at −80 °C prior flow
cytometry analysis. The preparation of nuclei for flow cytometric DNA analysis
was performed according to Vindelov et al. (1983). Stained cells were scanned
in a Becton Dickinson FACSCalibur flow cytometer, and the cell cycle profile
was quantified using Cellquest and ModFit software.
Results
CDC25B transcriptional activation correlates with domains of
Shh activity
We used the chick embryo as a model to define the
expression domains of CDC25B by in situ hybridization
during embryonic development. We observed an asymmetric
expression of CDC25B on the left of Hensen's node from
stage 5HH (Hamburger and Hamilton, 1992) onwards (Figs.
1a, c and data not shown) correlating with the asymmetric
expression of Shh reported during and after gastrulation
(Levin et al., 1995). In stage 10HH embryos, the transcripts
are absent from the most caudal aspect of the neuroepithelium
(Figs. 1d, e, h) where Shh activity could be inhibited by FGF
signaling (del Corral et al., 2003; Novitch et al., 2003).
However, they are present on both sides of the floor plate
(Figs. 1b, g) and display a ventro-dorsally decreasing gradient
in the closing neural tube (Figs. 1g, f), as previously observed
for Shh target genes such as Gli1 (Lobjois et al., 2004). In 3-
day-old embryos (stage 18HH), CDC25B is still expressed in
a discrete ventral domain in the neural tube (Fig. 1i). In later
stage embryos (stage 22–23 HH), CDC25B is broadly
expressed in the developing spinal cord, including the dorsal
region, and appears in the dorsal root ganglia (Fig. 1k),
suggesting that, from that stage, CDC25B transcription is not
Fig. 1. The spatio-temporal pattern of expression of CDC25B evokes a Shh-responding gene. (a–k) CDC25B expression visualized by in situ hybridization in chicken
embryos. (a) Dorsal view of a stage-7 embryo; (b, c) cross-sections of panel a; note the asymmetric expression at the level of Hensen's node (arrows in panels a and c).
(d, e) Dorsal views of a stage-10–11 embryo; panel e is a higher magnification of the caudal region in panel d; (f–h) cross-sections of panel d; note the ventro-dorsal
gradient in the neural tube and the absence of staining in the floor plate (f, g). (i) Cross-section of stage-18 embryo showing the staining in the neural tube at the level of
the wing bud. (j) Dorsal view of the wing bud of the same embryo; note the higher posterior expression of CDC25B (the double arrow marks the antero (A)-posterior
(P) axis); (k) cross-section of stage-23 embryo, showing a discrete domain of expression in the ventral part of the ventricular zone, strong staining at the lateral border
of the ventricular zone along the dorso-ventral axis and faint staining along the lumen (arrow); the asterisks mark the dorsal root ganglia, which are also positive. Cross-
sections are oriented dorsal to the top in all panels.
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also be regulated in a cell cycle-dependent fashion (Kakizuka
et al., 1992). In the limb bud of 3-day-old embryos, CDC25B
is expressed in a decreasing postero-anterior gradient in the
mesenchymal cells (Fig. 1j and data not shown) evolving into
a distal domain expanding along the anterior–posterior axis of
the limb bud at later stages (see below Fig. 5, and data not
shown), as previously described for Shh target genes (Marigo
et al., 1996). All together, these data establish that, during
early embryonic development, domains of Shh activity
coincide with high levels of CDC25B transcripts, suggesting
that Shh may regulate CDC25B expression.
Other actors controlling the G2/M transition are not restricted
to zones of Shh activity
To determine whether other cell cycle regulators acting at the
G2-M transition are preferentially expressed in zones of Shh
activity, we first investigated whether cyclin B and CDK1
transcripts were also upregulated in Shh-responding domains.
In 2-day-old chicken embryos, both cyclin B (data not shown)
and CDK1 (Figs. 2a–d) are ubiquitously expressed. In both
cases, we also observed scattered cells displaying a higher level
of transcripts, for instance, in the neuroepithelium (Figs. 2b–c,
arrows), but these had no obvious relationship to Shh-
responding domains, since they could be observed dorsally as
well as ventrally. In 2-day chicken embryos, the widespread
expression of CDK1 in the neural tube correlates well with the
fact that at this stage most of the cells are proliferating, as
visualized by BrdU incorporation (Figs. 2e–g). This confirmsthat transcription of CDK1 or cyclin B cannot be correlated with
domains of Shh activity.
The coincidence we observed between Shh-responding
domains and CDC25B transcription prompted us to examine
the expression pattern of CDC25A, the second CDC25
phosphatase that was identified in the chicken genome.
Interestingly, CDC25A also displays discrete domains of
expression, in some respects complementary to those of
CDC25B. For example, in 2-day-old embryos, the transcripts
are detected in the posterior part of the neuroepithelium (Figs.
2h–l compare with Figs. 1d–h); then they gradually diminish in
the ventral part of the closing neural tube and resolve to a clear
dorso-ventrally decreasing gradient in the closed neural tube
(Figs. 2j, k). One day later, the transcripts are predominantly
expressed in the dorsal part of the neural tube (Fig. 2o). In the
limb bud, CDC25A is broadly expressed in the mesenchyme
along the proximo-distal axis and in scattered cells in the
ectoderm (Figs. 2m, n). Taken together, these data show that
transcripts encoding regulators of the G2-M transition, such as
CDK1 and cyclin B, are widely expressed in the developing
embryo, while those encoding the CDC25 phosphatases display
specific domains of expression, suggesting that at least part of
their regulation is linked to specific signaling pathways.
CDC25B responds to the Shh/Gli pathway in the chicken
neural tube
To demonstrate unambiguously that transcription of the
phosphatase CDC25B responds to Shh signaling, we chose the
chicken neural tube as a model system. We first examined the
Fig. 2. Regulators at the G2-M transition other than CDC25B are not restricted to domains of Shh activity. (a–d) CDK1 expression visualized by in situ hybridization.
(a) Dorsal view of a stage-10 embryo; (b, d) cross-sections of panel a; CDK1 is ubiquitously expressed with scattered cells expressing higher levels (arrows in panels b
and c). (e–g) Immunostaining showing BrdU incorporation in cross-sections of a stage-10 embryo. Note the lower density at the midline, where the floor plate is
differentiating (white arrows). (h–o) CDC25A expression visualized by in situ hybridization in chicken embryos. (h, i) Dorsal views of a stage-10–11 embryo; panel i
is a higher magnification of the caudal region in panel h; (j–l) cross-sections of panel h; note that the expression pattern in the neural tube is roughly complementary to
that of CDC25B (compare with Figs. 1d–h); (m) dorsal view of the wing bud in a stage-18 embryo (the double arrow marks the antero (A)-posterior (P) axis); cross-
section of the same embryo showing the expression along the dorso(D)-ventral(V) axis (double arrow) and the gradient of expression along the proximo-distal axis
(proximal is to the right, distal to the left). Cross-sections are oriented dorsal to the top in all panels.
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expression, by transfecting a Shh-expression construct in the
caudal neural plate of HH stage-10 chicken embryos using in
ovo electroporation. As shown in Figs. 3a–c, 6–7 h after Shh
transfection, CDC25B was clearly induced ectopically on the
electroporated side (n = 24/30). Despite the fact that only a few
cells misexpressed Shh, increased levels of CDC25B transcripts
could be seen throughout the lateral wall of the neuroepithe-
lium, clearly indicative of a non-cell autonomous effect, as
would be expected from a regulation by a diffusible molecule.
This upregulation of CDC25B was observed within 6 h;
considering that the transgene (GFP) is first detected only 2–3 h
after electroporation, this means that upregulation of CDC25B
occurs in less than 6 h. CDC25B expression was unchanged in
embryos transfected with an empty vector (n = 0/28; data not
shown).
We then tested whether Shh could also affect CDC25A
expression. In response to a robust forced expression of Shh, the
amount of CDC25A transcripts was, at best, only slightly
increased (Figs. 3d–f) (7/12 experimental embryos displayed a
minor upregulation, as shown in Fig. 3f, whereas 5/12
experimental and 8/8 control embryos were unaffected).
Together, these data show that Shh activity is able to induce a
high level of CDC25B expression in the neural tube, while it
barely increases that of CDC25A.
To further investigate the role of the canonical Shh/Gli
pathway in the upregulation of these phosphatases, we
assayed the expression of CDC25B (Figs. 3g–i) and
CDC25A (Figs. 3j–l) 6 h after transfection of dominant
constitutive Gli2 or Gli3 activator constructs (Gli2ΔN-term,Gli3ΔN-term; Lei et al., 2004). Misexpression of dominant
activator forms of Gli2 (Figs. 3g–l) or Gli3 (data not shown)
induced an upregulation of CDC25B (n = 7/8) and of
CDC25A (n = 11/13). This observation indicated that both
phosphatases respond to the Shh/Gli signaling pathway in
gain-of-function experiments, even though, in a normal neural
tube, only the domain of CDC25B expression is consistent
with such a regulation. Interestingly, we were able to detect
transgenic cells that also expressed CDC25B or CDC25A
transcripts (Figs. 3i, k), suggestive of a cell-autonomous
induction of these phosphatases.
We then sought to determine whether the expression of
CDC25B in the neuroepithelium is Shh-dependent. We blocked
the Shh signaling pathway by cyclopamine treatment (Incardona
et al., 1998), a strategy that we preferred to misexpression of a
dominant inhibitory Gli protein (Gli3R), which results in
extensive cell death within 6 h of electroporation in the neural
tube (Cayuso et al., 2006). Cyclopamine complexed with 2-
hydroxypropyl-β-cyclodextrin (HBC) as a carrier or HBC alone
was injected in the neural tube and neural groove of stage-9–10
chicken embryos and the effect was analyzed 3 to 6 h later.
Cyclopamine injection resulted in a dramatic reduction of the
expression of CDC25B in a dose-dependent manner (Fig. 3m).
As in the gain-of-function experiments, the effect was very
rapid, since the downregulation of CDC25B was already
apparent after 3 h (n = 10/10 and n = 0/8 respectively for
treated and control embryos). We therefore conclude that Shh
signaling is critical for transcriptional activation of CDC25B in
the neural tube. The expression of CDK1 (data not shown, n = 0/
5) or CDC25A (Fig. 3n) was not significantly affected by
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regulates the transcription of CDC25B.
CDC25B is also expressed in the mouse neural tube and
impeded in Shh mutant mice
Because of the importance of Shh in the control of cell
proliferation in normal and cancer tissues, we wished to know
whether the link we have established between the hh pathway
and the cell cycle machinery in chicken is conserved in
mammals. A previous analysis of CDC25B (referred to there
as CDC25M2) transcripts during mouse development reported
that the gene was expressed in a developmentally regulated
and cell cycle-dependent fashion (Kakizuka et al., 1992). We
therefore asked whether the CDC25B transcript is upregulated
in domains of Shh activity. Analysis of the CDC25B
expression pattern in 8.5–9 dpc mouse embryos (corre-
sponding to stages 10–14 in chicken) confirmed that CDC25B
transcripts are present in the developing spinal cord (Fig. 4a).
As we showed in the chicken embryo, CDC25B is absent
from the caudal neuroepithelium and present in the closing
neural tube; the transcript was present in the entire neural tube
and we were unable to discern a ventro-dorsal gradient of
expression like that seen in chicken embryos. Furthermore, we
clearly saw scattered cells expressing a higher level of
transcripts both in the ventral and dorsal neural tube (arrow in
Fig. 4a). In 10.5-dpc mouse embryos, CDC25B is still widely
expressed in the alar plate of the spinal cord (Fig. 4b). In the
basal plate, the expression has become less uniform with,
flanking the floor plate, a discrete domain expressing
CDC25B (arrow in Fig. 4b) next to a domain of low or no
expression. In other words, there are common features and
clear differences in the spatio-temporal expression of CDC25B
in the neural tube of mouse and chick embryos. In both
species, transcripts are absent from the caudal neuroepithelium
and appear only in the closing neural tube. However, whereas
in the chicken neural tube CDC25B appears as a ventro-
dorsally decreasing gradient, in a discrete domain in the basal
plate, expanding to the dorsal aspect of the neural tube only at
later stages, in the mouse embryo, the transcript appears
simultaneously in the dorsal and ventral parts of the neural
tube.
We nevertheless wondered whether CDC25B expression
requires Shh activity in the mouse neural tube. To answer this
question, we analyzed the expression pattern of CDC25B in
Shh−/− mice (Chiang et al., 1996) at 9.5 and 10.5 dpc. AsFig. 3. Modulating Shh signaling strongly affects CDC25B expression. (a–c) Misexpr
leads to an upregulation of CDC25B (transcripts are detected in blue) within 6 h. The e
to induce CDC25B upregulation throughout the electroporated neuroepithelium. (d–f)
Panels b, c, and e, f are, respectively, cross-sections through panels a and d. (g–l) M
visualized here by detection ofGFP transcripts) in the neural tube leads to an upregula
can act in a cell-autonomous manner, as suggested by the presence of cells stained b
upregulation of CDC25A occurs prior to detection of the endogenous transcript (k,
increasing concentrations of cyclopamine (μg/ml; as indicated above the photos) a
cyclopamine treatment has no effect on CDC25A expression. The numbers represent
total number of embryos analyzed.shown in Fig. 4d, the activation of CDC25B transcription is
delayed in the neural tube of 9.5-dpc mutant embryos (n = 2/
2) compared to heterozygote littermates (Fig. 4c), the
transcript being detectable some time after the closure of the
neural tube (Fig. 4d). It may be argued that this late activation
is only the result of a growth delay of the Shh−/− embryos,
but CDC25B transcripts are already detected in the caudal
neural tube of younger wild-type embryos (compare Fig. 4d,
level 4 with Fig. 4a, level 1). Whereas in wild-type and
heterozygote embryos CDC25B is detected both in the ventral
and dorsal neural tube, in Shh−/− mice, although dorsal
expression appears unaffected, ventral expression is limited to
a few scattered cells predominantly located at the ventral
midline (Fig. 4d). The neural tube of Shh mutant embryos
does not develop a basal plate (ventral half) and displays only
alar plate (dorsal half) characteristics (Chiang et al., 1996).
Indeed, CDC25B expression in rostral regions of 9.5-dpc
mutant embryos resemble that of the alar plate (compare Fig.
4d, levels 1 and 2 with the dorsal half of the neural tube Fig.
4c, levels 1 and 2) even if the ventral expression is still
reduced. We observed the same defaults at 10.5 dpc (n = 2/2)
(Fig. 4f). CDC25B transcripts are absent from the caudal
neural tube; they appear first in the dorsal part of the neural
tube (Fig. 4f, level 3), expanding in the entire neural tube in
more rostral regions (Fig. 4f, level 1). In conclusion, the
delayed upregulation of CDC25B in Shh mutant embryos
particularly in the ventral part of the neural tube, strongly
suggests that the Shh signaling pathway contributes to the
upregulation of CDC25B in the mouse as well.
CDC25B transcription is regulated by Shh activity in the limb
bud of chick and mouse embryos
We then turned to the limb bud and found that, in 10.
dpc mouse as in the chick, CDC25B transcripts are pre-
ferentially expressed in the posterior aspect of the limb bud
(Fig. 4b). These data suggest that the transcriptional
regulation of CDC25B may be partly controlled by Shh
activity in that structure as well. To confirm that CDC25B
expression in the limb bud depends upon Shh activity, we
analyzed the expression pattern in Shh mutant mice.
CDC25B transcripts are virtually absent from the limb bud
of Shh−/− mice (Figs. 5c–d; n = 4/4), since they are only
detected in scattered cells reminiscent of migrating myogenic
precursors (Figs. 5a–d, arrowheads) (Buckingham et al.,
2003). These results support the conclusion that Shh activityession of Shh (transcripts are detected in red) in the neural groove and neural tube
ffect is non-cell-autonomous, since only a few Shh-expressing cells are sufficient
Misexpression of Shh in the neural tube has little effect on CDC25A expression.
isexpression of a dominant activator form of Gli2 (transgenic cells are in red,
tion of CDC25B (in blue, g–i) or CDC25A (in blue j–l) within 6 h. The transgene
oth for GFP and for CDC25B (i) or CDC25A (k). Note that the Shh-dependent
l). (m) Dorsal views of whole-mount stage-10–11 embryos treated for 6 h with
nd analyzed for CDC25B expression by in situ hybridization. (n) In contrast,
the number of embryos showing a staining equivalent to that on the picture/the
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limb buds. To ascertain whether CDC25B responds to Shh
signaling in the limb bud, we implanted pellets of Shh-
expressing cells (Pourquie et al., 1996) into the anterior
margin of 3.5-day-old chicken embryos (Fig. 5e). Exposure
of limb bud cells to Shh-expressing cells for 6–7 h induced
ectopic upregulation of CDC25B (n = 9/9 and n = 0/6,
respectively for Shh-QT6 and control-QT6 grafted embryos)
(Figs. 5e–f). Thus, we conclude that Shh contributes to theupregulation of CDC25B expression in the limb bud of
vertebrate embryos.
Arresting the cell cycle does not reduce CDC25B expression
while inhibition of the Shh pathway affects CDC25B
expression without cell cycle arrest
CDC25B can be transcriptionally regulated in a cell cycle-
dependent fashion, transcripts accumulating in S phase and
Fig. 4.CDC25B also displays a developmentally restricted expression pattern in the m
p.c mouse embryo. (a) Lateral view of the embryo; 1, 2, 3: cross-sections of panel a
appears in the closing neural groove (level 2) and is absent from the most dorsal aspec
in 1). (b) Lateral view of a 10.5-dpc embryo (the head has been removed); CDC25B is
section performed at the level of the white line in panel b; note that the section has b
cord is now at the top and the antero-posterior axis of the limb bud is as indicated by t
limb bud. CDC25B is also strongly expressed in the dorsal spinal cord and in a disc
heterozygous embryo (21 somites). 1–4: cross-sections performed at the level shown
are detected in the closed neural tube (3–4) and are strongly expressed along the entir
the level of the bracket in 2, the staining is reinforced laterally, reminiscent of the exp
1k). Again we observe scattered cells expressing a higher level of transcripts (1–4). T
9.5-dpc Shh-mutant embryo (19 somites). 1–4: cross-sections performed as indicated
4) and the presence of the transcripts mainly in the dorsal part of the neural tube in m
ventral part of the neural tube. (e) Lateral view of a 10.5-dpc Shh-heterozygote emb
10.5-dpc Shh-mutant embryo. 1–3: cross-sections performed as indicated in panel f
mainly present in scattered cells located dorsally (3). In more rostral regions (1–2),
Fig. 5. CDC25B responds to Shh signaling in the limb bud of both mouse and
chicken embryos. (a–d) CDC25B expression is strongly reduced in the limb bud
of Shh−/− embryos. While CDC25B is still present in the neural tube (NT) of
Shh−/− embryos (c, d), the posterior domain of CDC25B expression, clearly
detectable in the limb bud of wt littermates or heterozygous embryos (a, b), is
absent in the mutants (c, d). Interestingly, scattered cells expressing CDC25B are
visualized in the limb bud of both wild-type (a, b, arrows) and mutant embryos
(c, d, arrows). (e–f) Grafting cells expressing Shh (arrows in e) into the anterior
margin of the limb bud of a 3.5-day-old chicken embryo induce a clear
upregulation of CDC25B within 6 h. Implanting a pellet of the corresponding
control cells at the anterior margin of the limb bud in the same conditions has no
effect (arrows in f). The pellets appearing in light brown were detected by
immunocytochemistry using the QCPN antibody.
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(Kakizuka et al., 1992). Shh being well known to favor
proliferation, we could not exclude that the upregulation of
CDC25B in domains of Shh activity was an indirect
consequence of the Shh-dependent proliferation. To determine
whether it was the case, we blocked the cell cycle progression
by aphidicolin treatment and looked at CDC25B expression.
Aphidicolin impedes DNA replication (Pedrali-Noy et al.,
1980) and, as expected, neural tubes of treated embryos stopped
to incorporate BrdU already after 3 h of treatment (Figs. 6a, b).
The cell cycle arrest was validated by the virtual absence of
mitotic cells in aphidicolin-treated embryos (Fig. 6b, data not
shown). In these experimental conditions, CDC25B transcript
level was not reduced and moreover the ventro-dorsal gradient
of expression was still apparent in the ventral neural tube. To
our surprise, the staining seemed even stronger in treated versus
control embryos (compare Figs. 6c and f; n = 4/5 embryos).
This observation prompted us to verify if aphidicolin-treated
neural tubes contained cells arrested in G2 phase since the cell
cycle-dependent expression of CDC25B peaks in G2 and
aphidicolin has been shown to affect the G2 to M transition in
some conditions (Fukuda and Ohashi, 1983; Tanaka et al.,
1998). A flow cytometry analysis performed on neural tubes
explanted from aphidicolin-treated embryos revealed that a
substantial number of cells in G2 were still present (Fig. 6i;
n = 6 samples of 3 neural tubes each). Similar results were
obtained with higher doses of aphidicolin (up to 16 μM), longer
treatment (up to 4 h then cell cycle arrest becomes toxic for the
embryo) and the use of other cell cycle inhibitors (including
hydroxyurea and mimosin) (data not shown). Therefore, we
cannot ascertain that the ventral expression of CDC25B is
entirely cell cycle-independent since it may be due to the
remaining G2 cells. Furthermore, since Shh has been shown to
act on the cell cycle primarily by facilitating the G1 to S
transition (occurring before the step in the cell cycle where the
drugs act), we cannot totally exclude the possibility that its
effect on CDC25B is still an indirect downstream consequence
of cells making it through the G1/S transition.
However, if the ventral expression of CDC25B was
exclusively cell cycle-dependent, due to cells passing the G1/
S transition or to cells in G2 phase, cyclopamine-treated neural
tubes in which CDC25B expression is drastically diminishedouse embryo. (a) CDC25B expression visualized by in situ hybridization in a 9-d.
; note the absence of staining in the caudal neural epithelium (a, 3); the staining
t of the neural tube. Some scattered cells display a higher level of staining (arrows
expressed in the neural tube and in the posterior part of the limb bud. b-1, cross-
een rotated along the vertical axis compared to the embryo in panel b, the spinal
he double arrow. Note the staining in the posterior, but not anterior, region of the
rete domain flanking the floor plate (arrow). (c) Lateral view of a 9.5-dpc Shh-
in panel c; CDC25B transcripts, absent from the most caudal part of the embryo,
e dorso-ventral axis of the neural tube in more rostral regions (1–2). Note that, at
ression pattern observed in the spinal cord of stage-23 chicken embryos (see Fig.
he arrowhead marks the position of the anterior limb bud. (d) Lateral view of a
in panel d. Note the absence of CDC25B expression in the closed neural tube (3–
ore rostral regions (1–2); only a few scattered positive cells are detected in the
ryo. 1–3: cross-sections performed as indicated in panel e. (f) Lateral view of a
; CDC25B expression is strongly reduced in the caudal neural tube, where it is
the staining expands ventrally.
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reduction of the percentage of cells in S and G2. To examine this
hypothesis, we dissected neural tube regions of cyclopamine-
treated embryos and performed cell cycle analysis using flow
cytometry (Fig. 6p). We observed that DNA profiles from
cyclopamine-treated embryos (n = 9 samples of 3 neural tubes
each) were not severely altered compared to those obtained for
HBC-treated embryos (n = 9 samples of 3 neural tubes each)
and mitotic cells were still present in cyclopamine-treated
embryos (Figs. 6m–o). The percentage of cells in G1 is
significantly lower in control embryos (47.7 ± 1.4% SEM) than
in cyclopamine-treated embryos (50.8 ± 0.6% SEM), while the
percentage of cells progressing through S phase dropped from
33% (±1.3% SEM) for control embryos to 28.8% (±0.6% SEM)
for cyclopamine-treated embryos. However, the percentage of
cells in G2 + M is not significantly different in control
(19.2 ± 0.8% SEM) versus cyclopamine-treated embryos
(20.3 ± 0.8% SEM) (Fig. 6p). Thus, we can conclude that the
loss of CDC25B expression that we observed in the cyclopa-
mine experiments is not related to major changes in cell cycle
distribution.
Taken together, the observation that the gradient of CDC25B
is still present in the neural tube after cell cycle arrest and the
finding that the level of CDC25B transcripts is strikingly
reduced in cyclopamine-treated embryos without drastic
perturbation of the cell cycle (87% of the cells pass through
the G1/S transition and there is no reduction of the G2+M
population) strongly suggest that Shh is able to upregulate
CDC25B independently of its effect on proliferation.
Discussion
The CDC25 phosphatases are transcriptionally regulated by
signaling pathways during development
The CDC25 phosphatases are well known to be transcrip-
tionally regulated in a cell cycle-dependent fashion (Jinno et al.,
1994; Kakizuka et al., 1992; Nagata et al., 1991; Sadhu et al.,
1990). The expression of CDC25B is up regulated during cell
cycle progression, transcripts accumulating in S phase and
remaining elevated until the G2-M transition, finally disappear-
ing in G1 (Kakizuka et al., 1992). The present study establishes
that modification of Shh activity leads to rapid changes of
CDC25B level of expression in the embryo suggesting that part
of its transcriptional regulation is linked to that signaling
pathway.Fig. 6. Effect of cell cycle arrest on CDC25B transcription. (a, b) Cross-sections of ne
analyzed for BrdU labeling (red) and P-H3 immunostaining (green). (c–h) CDC25B
(f–h) treated embryos. (c, f) Dorsal view of a stage 11 embryo; (d, e, g, h) cross-sectio
both control and treated embryos. A single cell expressing CDC25B is clearly visible
stronger in aphidicolin-treated embryo. (i) Representative DNA profiles of DMSO- or
treated embryos, pooled and proceeded for flow cytometric DNA analysis. The cell c
mean ± SEM (6 independent samples for each condition) of the percentage of cells in
situ hybridization (blue) and P-H3 visualized by immunodetection (brown) in embry
stage-10 embryo; (k, l, n, o) cross-sections respectively of panels j and m; note the
Representative DNA profiles of HBC- or cyclopamine-treated neural cells. Analysis w
independent samples for each condition.We accumulate data suggesting that the effect of Shh on
CDC25B is not an indirect consequence of the Shh-dependent
action on proliferation. The fact that expression of other G2/M
regulators such as CDK1, cyclin B and CDC25A is not affected
in the Shh loss-of-function experiments argues against the latter
possibility. Furthermore in these experiments, modulation of
CDC25B expression is very rapid (respectively less than 6 h and
3 h). The length of the cell cycle in the neural tube has been
estimated between 6.3 and 8 h (Langman et al., 1966; Smith and
Schoenwolf, 1987). The regulation of CDC25B thus occurs in
less time than the length of the cell cycle, making it highly
unlikely that the effect of Shh on CDC25B is an indirect
consequence of an overall modification of proliferation. Finally,
blocking the cell cycle did not reduce the level of CDC25B
transcripts while cyclopamine treatment downregulates
CDC25B expression without drastic modification of the cell
cycle suggesting once again that Shh regulates CDC25B
expression not as a consequence of its effect on proliferation.
We also show that misexpression of a dominant-constitutive
Gli activator construct induces a marked upregulation of
CDC25B expression, suggesting that the canonical Shh/Gli
pathway operates in this case. The challenge is now to identify
the molecular cascade linking the Shh/Gli pathway to CDC25B
regulation. It may be directly mediated via Gli transcription
factors, since Gli binding motifs are present in the murine
CDC25B genomic sequence (B.B. unpublished observations).
As yet, we do not know if such binding sites are also present in
the chicken genome, in which CDC25B has still not been
localized. Another particularly interesting track to follow is the
idea of that regulation is indirect, via the transcription factor
FoxM1. FoxM1 has been shown to be a target of Gli1 in basal
cell carcinomas (Teh et al., 2002) and the CDC25B phosphatase
is a transcriptional target of FoxM1 (Costa, 2005; Wang et al.,
2002). Unfortunately, experiments involving cycloheximide,
which could be an easy way to determine whether the regulation
of CDC25B via the Shh/Gli pathway is direct or indirect, are
precluded, since cycloheximide treatment by itself results in a
drastic increase of CDC25B transcripts, such as has been
observed in the case of many highly unstable mRNAs
(Kakizuka et al., 1992; B.B. unpublished observations).
In the cell cycle blocking experiments, we observe a double
block at the G1 to S and G2 to M transitions even when we used
high doses of aphidicolin known to arrest cells preferentially at
G1/S phase, either because the population of neural progenitors
is asynchronous or because it displays a specific response to cell
cycle arrest. We noticed an upregulation of CDC25B which canural tubes of stage-10–11 embryos treated for 3 h with DMSO or aphidicolin and
expression visualized by in situ hybridization in DMSO- (c–e) and aphidicolin-
ns respectively of panels c and f; note the ventral expression in the neural tube of
outside the ventral domain of expression in panel d (arrowhead). The staining is
aphidicolin-treated neural cells: three neural tubes were dissected from control or
ycle profile was quantified using ModFit software and histogram represents the
the different phases of the cell cycle. (j–o) CDC25B expression visualized by in
os treated for 6 h with HBC (j–l) or cyclopamine (m–o). (j, m) Dorsal view of a
presence of P-H3 positive cells in the cyclopamine-treated embryo (n, o). (p)
as performed as described in panel i. Histogram represents the mean ± SEM of 9
144 B. Bénazéraf et al. / Developmental Biology 294 (2006) 133–147reflect an abnormal accumulation of transcripts in that
population of cells arrested in G2 phase. Indeed, we also
observed an expression of CDC25B that is suggestive of a cell
cycle-dependent regulation in the spinal cord. In early stages,
we sometimes observed few scattered cells faintly stained
outside the ventral domain of expression (see arrow on Fig. 6d).
In later stages, CDC25B is strongly expressed in both the
ventral and dorsal aspects of the spinal cord and is restricted
along the apico-basal axis, being stronger basally at the border
of the ventricular zone and present in some cells along the
lumen. In the ventricular zone, nuclei and surrounding
cytoplasm undergo radial movements as a function of the cell
cycle, chromosome replication occurring basally and mitosis at
the apical surface, the G1 and G2 cells being located at
intermediate positions. Therefore, the spatial distribution of the
transcripts in the ventricular zone at later stages of spinal cord
development is suggestive of a cell cycle-dependent regulation,
while the uniform expression observed in the ventral aspect of
the neural tube evokes a Shh-dependent regulation. In the
mouse neural tube, unlike in the chick, CDC25B upregulation
occurs simultaneously in the basal and alar plates, with scattered
cells expressing higher levels in both domains. In Shh−/−
mutant embryos, the upregulation of CDC25B is delayed in
general, the dorsal component appearing first, in an almost
normal manner, the ventral one being strongly reduced,
transcripts appearing in the ventral part of mutant embryos
only at later stages. The spatio-temporal upregulation of
CDC25B in these mutants indicates that the dorsal and ventral
domains of expression are regulated differently. The dorsal
expression is mainly Shh-independent, possibly related to a
dorsal signal, whereas the Shh signaling pathway may play a
role in the ventral expression.
In the chicken embryo, we have also observed that
CDC25A expression is regionalized during early development,
while the expression of other G2/M regulators is not.
Furthermore in the spinal cord primordium, CDC25A seems
roughly complementary to CDC25B, being present in the
caudal neural groove while CDC25B appears in the closing
neural tube and displaying a dorso-ventrally decreasing
gradient whereas CDC25B shows an opposite one. Conse-
quently, CDC25A is probably linked to a specific signaling
pathway which remains to be identified. In the present study,
we detected an upregulation of CDC25A transcription in the
Shh gain-of-function experiments, suggesting that this phos-
phatase can also be transcriptionally activated by the Shh/Gli
pathway. However, the fact that, in the developing neural tube,
the spatio-temporal upregulation of CDC25A does not
correlate with the domains of Shh activity and that finding
that the level of CDC25A transcripts is not significantly
affected in loss-of-function experiments suggest that this
pathway is not the major upregulator of the expression of
this gene at that time. It is thus interesting to note that the
decreasing dorso-ventral gradient of CDC25A transcripts in the
neural tube correlates with the dorso-ventral gradient of cell
proliferation controlled by the Wnt signaling pathway (Mega-
son and McMahon, 2002). In the light of all these results, we
propose that the CDC25 phosphatases are specificallyregulated by signaling pathways that govern the developmental
process, thus establishing an unexpected link between these
pathways and regulators of the cell cycle machinery acting at
the G2-M transition.
Shh controls expression of regulators acting at the G1/S and
G2/M transitions
Numerous examples, including during CNS development
(cf. introduction), reports that the positive regulators of G1
progression, cyclin D1 and D2, are transcriptional targets
mediating the mitogenic response of Shh (Dahmane and Ruiz-i-
Altaba, 1999; Kenney and Rowitch, 2000; Kenney et al., 2003;
Oliver et al., 2003; Wallace, 1999; Wechsler-Reya and Scott,
1999). We also showed that, in the developing spinal cord, Shh
specifically activates cyclin D1 expression (Lobjois et al., 2004)
and accordingly, we observe that blocking the Shh pathway
hinders the G1 to S transition (this study). Here we show that
Shh also controls the expression of one of the regulators of the
G2/M transition, the phosphatase CDC25B. The Shh mitogenic
signal could thus influence cell cycle progression by controlling
expression of different cell cycle regulators: cyclins D acting in
G1 progression and CDC25B phosphatase acting at the G2/M
transition.
The hypothesis that Shh exerts a control at the G2-M
transition is supported by recent data showing a link between
the Shh signaling pathway and another actor of the G2/M
transition, cyclin B1 (Barnes et al., 2001). In cell lines, the
receptor of Shh, Patched1, is able to interact with cyclin B1
thus maintaining it in the cytoplasm. Addition of Shh disrupts
this interaction and allows cyclin B1 to enter the nucleus,
possibly allowing the formation of the cyclin B1-CDK1
(MPF) complex. Therefore, we propose that Shh positively
regulates G2/M progression in two complementary ways: first,
by the release of cyclin B1 from Ptc, allowing the nuclear
localization of MPF, second by upregulation of CDC25B
expression, thereby activating the MPF complex required for
the entry into mitosis.
The functional relevance of the link between the Shh
pathway and the G2/M transition remains to be elucidated.
CDC25B displays discrete domains of expression during
mouse development (Kakizuka et al., 1992 and this study) and
we show that it is regulated by Shh in the ventral neural tube
and in the limb bud. On the other hand, CDC25B−/− mice are
viable and healthy, although females are sterile due to a
meiotic defect during oogenesis (Lincoln et al., 2002).
CDC25A and CDC25C are also expressed in the mouse
limb bud (B.B. unpublished observation) and therefore may
functionally compensate for CDC25B but it should be noticed
that mice lacking both CDC25B and CDC25C do not display
developmental or mitotic defects (Ferguson et al., 2005). The
fact that we found only two CDC25 phosphatases (A and B)
in the chicken genome and that they display complementary
patterns in the developing neural tube set up a putative
suitable model system to elucidate the developmental function.
In the neural tube, the upregulation of CDC25B via Shh may
be correlated to two events: an increase in the mitotic density
145B. Bénazéraf et al. / Developmental Biology 294 (2006) 133–147in the ventral neural tube (Corliss and Robertson, 1963) and
the onset of neuronal differentiation occurring soon after (Diez
del Corral et al., 2002). It is interesting to notice that in
addition to its classical role in mitosis CDK1/cyclin B activity
has also been implicated in cell cycle exit and in asymmetric
cell division. In the cerebellar granule neuron precursors,
CDK1 complexes play a prime role in regulating N-myc
phosphorylation-mediated degradation thus favoring cell cycle
exit (Kenney et al., 2004; Sjostrom et al., 2005). In
Drosophila, asymmetric divisions of neural progenitors require
high levels of CDK1/cyclin B activity to maintain the
asymmetric localization of the apical components during
mitosis (Tio et al., 2001). Vertebrate neural progenitor cell
divisions exhibit some characteristic features of asymmetric
invertebrate cell divisions suggesting that segregating deter-
minants are involved here as well in the making of neurones
(Betschinger and Knoblich, 2004). It is then tempting to
speculate that the upregulation of CDC25B by Shh in the
neural tube may boost up mitosis in the ventral neural tube
and/or favor cell cycle exit or asymmetric cell division to
promote the onset of neuronal differentiation. It should be kept
in mind that, beside its transcriptional regulation, CDC25B is
well known to be submitted to post-translational regulation
which will influence its stability and subcellular localization
(Dutertre et al., 2004; Mirey et al., 2005) and therefore may
also contribute to its timing of activation.
In conclusion, we have identified a cell cycle regulator,
CDC25B, which responds to Shh signaling during embryonic
development, both in chick and mice. Shh controls expression
of regulators acting at two key steps of the cell cycle:
progression through G1 (Lobjois et al., 2004; Ruiz et al.,
2002) and the G2/M transition (this study). While the control of
G1 progression may maintain discrete pools of cycling
progenitors (Lobjois et al., 2004), the significance of the
control of the G2/M transition remains to be clarified. It
nevertheless seems clear that, by virtue of its ability to regulate
the cell cycle, Shh can coordinate proliferation with the
patterning program at numerous steps of vertebrate develop-
ment. Since several types of cancer have been linked to
disruption of the hh pathway, identification of molecules that
link that pathway to cell cycle machinery is of major
importance, not only for an understanding of the mechanisms
underlying hh-dependent proliferation, but also because they
may represent putative therapeutic targets for cancer therapy.
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